Editorial: serotonin and irritable bowel syndrome - reconciling pharmacological effects with basic biology

被引：3
作者：
Quigley, E. M. M. [1 ,2 ]
机构：
[1] Houston Methodist Hosp, Div Gastroenterol & Hepatol, Lynda K & David M Underwood Ctr Digest Disorders, Houston, TX USA
[2] Weill Cornell Med Coll, Houston, TX USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2016年 / 43卷 / 05期
关键词：
DISORDERS; WOMEN;
D O I：
10.1111/apt.13501
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：644 / 646
页数：3
相关论文
共 11 条
[1]   Pharmacogenetics in irritable bowel syndrome [J].
Acosta, Andres ;
Camilleri, Michael .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (08) :1187-1191
[2]   Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity [J].
Bueno, L. ;
De Ponti, F. ;
Fried, M. ;
Kullak-Ublick, G. A. ;
Kwiatek, M. A. ;
Pohl, D. ;
Quigley, E. M. M. ;
Tack, J. ;
Talley, N. J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 :89-119
[3]   Serotonin: Current understanding and the way forward [J].
Dinan, TG .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :19-21
[4]   A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator [J].
Drossman, DA ;
Morris, CB ;
Hu, YM ;
Toner, BB ;
Diamant, N ;
Leserman, J ;
Shetzline, M ;
Dalton, C ;
Bangdiwala, SI .
GASTROENTEROLOGY, 2005, 128 (03) :580-589
[5]   Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity [J].
Fitzgerald, P. ;
Eugene, M. Cassidy ;
Clarke, G. ;
Scully, P. ;
Barry, S. ;
Eamonn, M. M. Quigley ;
Shanahan, F. ;
Cryan, J. ;
Timothy, G. Dinan .
NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (12) :1291-1297
[6]   The serotonin signaling system: From basic understanding to drug development-for functional GI disorders [J].
Gershon, Michael D. ;
Tack, Jan .
GASTROENTEROLOGY, 2007, 132 (01) :397-414
[7]   Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women [J].
Labus, J. S. ;
Mayer, E. A. ;
Jarcho, J. ;
Kilpatrick, L. A. ;
Kilkens, T. O. C. ;
Evers, E. A. T. ;
Backes, W. H. ;
Brummer, R-J M. ;
van Nieuwenhoven, M. A. .
GUT, 2011, 60 (09) :1196-1203
[8]   Serotonin and GI clinical disorders [J].
Spiller, Robin .
NEUROPHARMACOLOGY, 2008, 55 (06) :1072-1080
[9]   Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders [J].
Tack, J. ;
Camilleri, M. ;
Chang, L. ;
Chey, W. D. ;
Galligan, J. J. ;
Lacy, B. E. ;
Mueller-Lissner, S. ;
Quigley, E. M. M. ;
Schuurkes, J. ;
De Maeyer, J. H. ;
Stanghellini, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) :745-767
[10]   Alterations in serotonin metabolism in the irritable bowel syndrome [J].
Thijssen, A. Y. ;
Mujagic, Z. ;
Jonkers, D. M. A. E. ;
Ludidi, S. ;
Keszthelyi, D. ;
Hesselink, M. A. ;
Clemens, C. H. M. ;
Conchillo, J. M. ;
Kruimel, J. W. ;
Masclee, A. A. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (02) :272-282
12